Bill Text: OH HB501 | 2013-2014 | 130th General Assembly | Introduced

Ohio House Bill 501 (Prior Session Legislation)

Introduced

Bill Title: To add the drug Zohydro to the list of Schedule I controlled substances.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced - Dead) 2014-03-20 - To Health and Aging [HB501 Detail]

Download: Ohio-2013-HB501-Introduced.html

As Introduced

130th General Assembly

Regular Session

2013-2014

H. B. No. 501

Representatives Smith, Sprague

A BILL

To amend section 3719.41 of the Revised Code to add

the drug Zohydro to the list of Schedule I

controlled substances.

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:

Section 1. That section 3719.41 of the Revised Code be	4
amended to read as follows:	5

Sec. 3719.41. Controlled substance schedules I, II, III, IV,	6
and V are hereby established, which schedules include the	7
following, subject to amendment pursuant to section 3719.43 or	8
3719.44 of the Revised Code.	9

SCHEDULE I	10

(A) Narcotics-opiates

Any of the following opiates, including their isomers,	12
esters, ethers, salts, and salts of isomers, esters, and ethers,	13
unless specifically excepted under federal drug abuse control	14
laws, whenever the existence of these isomers, esters, ethers, and	15
salts is possible within the specific chemical designation:	16

(1) Acetyl-alpha-methylfentanyl	17
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);	18

(2) Acetylmethadol;

(3) Allylprodine;

(4) Alphacetylmethadol (except levo-alphacetylmethadol, also	21
known as levo-alpha-acetylmethadol, levomethadyl acetate, or	22
LAAM);	23

(5) Alphameprodine;

(6) Alphamethadol;

(7) Alpha-methylfentanyl	26
(N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide;	27
1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);	28

(8) Alpha-methylthiofentanyl	29
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-	30
phenylpropanamide);	31

(9) Benzethidine;

(10) Betacetylmethadol;

(11) Beta-hydroxyfentanyl	34
(N-[1-(2-hydroxy-2-phenethyl-4-piperidinyl]-N- phenylpropanamide);	35

(12) Beta-hydroxy-3-methylfentanyl (other name:	36
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-	37
phenylpropanamide);	38

(13) Betameprodine;

(14) Betamethadol;

(15) Betaprodine;

(16) Clonitazene;

(17) Dextromoramide;

(18) Diampromide;

(19) Diethylthiambutene;

(20) Difenoxin;

(21) Dimenoxadol;

(22) Dimepheptanol;

(23) Dimethylthiambutene;

(24) Dioxaphetyl butyrate;

(25) Dipipanone;

(26) Ethylmethylthiambutene;

(27) Etonitazene;

(28) Etoxeridine;

(29) Furethidine;

(30) Hydroxypethidine;

(31) Ketobemidone;

(32) Levomoramide;

(33) Levophenacylmorphan;

(34) 3-methylfentanyl	60
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N- phenylpropanamide);	61

(35) 3-methylthiofentanyl	62
(N-[3-methyl-1-[2-(thienyl)ethyl]-4-piperidinyl]-N-	63
phenylpropanamide);	64

(36) Morpheridine;

(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

(38) Noracymethadol;

(39) Norlevorphanol;

(40) Normethadone;

(41) Norpipanone;

(42) Para-fluorofentanyl	71
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide;	72

(43) PEPAP (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;

(44) Phenadoxone;

(45) Phenampromide;

(46) Phenomorphan;

(47) Phenoperidine;

(48) Piritramide;

(49) Proheptazine;

(50) Properidine;

(51) Propiram;

(52) Racemoramide;

(53) Thiofentanyl	83
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide;	84

(54) Tilidine;

(55) Trimeperidine;

(56) Zohydro.

(B) Narcotics-opium derivatives

Any of the following opium derivatives, including their	89
salts, isomers, and salts of isomers, unless specifically excepted	90
under federal drug abuse control laws, whenever the existence of	91
these salts, isomers, and salts of isomers is possible within the	92
specific chemical designation:	93

(1) Acetorphine;

(2) Acetyldihydrocodeine;

(3) Benzylmorphine;

(4) Codeine methylbromide;

(5) Codeine-n-oxide;

(6) Cyprenorphine;

(7) Desomorphine;

100

(8) Dihydromorphine;

101

(9) Drotebanol;

102

(10) Etorphine (except hydrochloride salt);

103

(11) Heroin;

104

(12) Hydromorphinol;

105

(13) Methyldesorphine;

106

(14) Methyldihydromorphine;

107

(15) Morphine methylbromide;

108

(16) Morphine methylsulfonate;

109

(17) Morphine-n-oxide;

110

(18) Myrophine;

111

(19) Nicocodeine;

112

(20) Nicomorphine;

113

(21) Normorphine;

114

(22) Pholcodine;

115

(23) Thebacon.

116

117

Any material, compound, mixture, or preparation that contains	118
any quantity of the following hallucinogenic substances, including	119
their salts, isomers, and salts of isomers, unless specifically	120
excepted under federal drug abuse control laws, whenever the	121
existence of these salts, isomers, and salts of isomers is	122
possible within the specific chemical designation. For the	123
purposes of this division only, "isomer" includes the optical	124
isomers, position isomers, and geometric isomers.	125

(1) Alpha-ethyltryptamine (some trade or other names:	126
etryptamine; Monase; alpha-ethyl-1H-indole-3-ethanamine;	127
3-(2-aminobutyl) indole; alpha-ET; and AET);	128

(2) 4-bromo-2,5-dimethoxyamphetamine (some trade or other	129
names: 4-bromo-2,5-dimethoxy-alpha-methyphenethylamine;	130
4-bromo-2,5-DMA);	131

(3) 4-bromo-2,5-dimethoxyphenethylamine (some trade or other	132
names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane;	133
alpha-desmethyl DOB; 2C-B, Nexus);	134

(4) 2,5-dimethoxyamphetamine (some trade or other names:	135
2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);	136

(5) 2,5-dimethoxy-4-ethylamphetamine (some trade or other	137
names: DOET);	138

(6) 4-methoxyamphetamine (some trade or other names:	139
4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine;	140
PMA);	141

(7) 5-methoxy-3,4-methylenedioxy-amphetamine;

142

(8) 4-methyl-2,5-dimethoxy-amphetamine (some trade or other	143
names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; "DOM"	144
and "STP");	145

(9) 3,4-methylenedioxy amphetamine (MDA);

146

(10) 3,4-methylenedioxymethamphetamine (MDMA);

147

(11) 3,4-methylenedioxy-N-ethylamphetamine (also known as	148
N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl	149
MDA, MDE, MDEA);	150

(12) N-hydroxy-3,4-methylenedioxyamphetamine (also known as	151
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine and	152
N-hydroxy MDA);	153

(13) 3,4,5-trimethoxy amphetamine;

154

(14) Bufotenine (some trade or other names:	155
3-(beta-dimethylaminoethyl)-5-hydroxyindole;	156
3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin;	157
5-hydroxy-N, N-dimethyltryptamine; mappine);	158

(15) Diethyltryptamine (some trade or other names: N,	159
N-diethyltryptamine; DET);	160

(16) Dimethyltryptamine (some trade or other names: DMT);

161

(17) Ibogaine (some trade or other names:	162
7-ethyl-6,6beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-	163
5H-pyrido[1',2':1,2] azepino [5, 4-b] indole; tabernanthe iboga);	164

(18) Lysergic acid diethylamide;

165

(19) Marihuana;

166

(20) Mescaline;

167

(21) Parahexyl (some trade or other names: 3-hexyl-1-	168
hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran;	169
synhexyl);	170

(22) Peyote (meaning all parts of the plant presently	171
classified botanically as "Lophophora williamsii Lemaire," whether	172
growing or not, the seeds of that plant, any extract from any part	173
of that plant, and every compound, manufacture, salts, derivative,	174
mixture, or preparation of that plant, its seeds, or its	175
extracts);	176

(23) N-ethyl-3-piperidyl benzilate;

177

(24) N-methyl-3-piperidyl benzilate;

178

(25) Psilocybin;

179

(26) Psilocyn;

180

(27) Tetrahydrocannabinols (synthetic equivalents of the	181
substances contained in the plant, or in the resinous extractives	182
of Cannabis, sp. and/or synthetic substances, derivatives, and	183
their isomers with similar chemical structure and pharmacological	184
activity such as the following: delta-1-cis or trans	185
tetrahydrocannabinol, and their optical isomers; delta-6-cis or	186
trans tetrahydrocannabinol, and their optical isomers;	187
delta-3,4-cis or trans tetrahydrocannabinol, and its optical	188
isomers. (Since nomenclature of these substances is not	189
internationally standardized, compounds of these structures,	190
regardless of numerical designation of atomic positions, are	191
covered.));	192

(28) Ethylamine analog of phencyclidine (some trade or other	193
names: N-ethyl-1-phenylcyclohexylamine;	194
(1-phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine;	195
cyclohexamine; PCE);	196

(29) Pyrrolidine analog of phencyclidine (some trade or other	197
names: 1-(1-phenylcyclohexyl)pyrrolidine; PCPy; PHP);	198

(30) Thiophene analog of phencyclidine (some trade or other	199
names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 2-thienyl analog	200
of phencyclidine; TPCP; TCP);	201

(31) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine;

202

(32) Hashish;

203

(33) Salvia divinorum;

204

(34) Salvinorin A;

205

(35)	206
(1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone	207
(UR-144);	208

(36) 1-pentyl-3-(1-adamantoyl)indole (AB-001);

209

(37) N-adamantyl-1-pentylindole-3-carboxamide;

210

(38) N-adamantyl-1-pentylindazole-3-carboxamide (AKB48);

211

(39) 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone	212
(methoxetamine);	213

(40) N,N-diallyl-5-methoxytryptamine (5MeO-DALT);

214

(41)	215
[1-(5-fluoropentylindol-3-yl)]-(2,2,3,3-tetramethylcyclopropyl)methanone	216
(5-fluoropentyl-UR-144; XLR11);	217

(42)	218
[1-(5-chloropentylindol-3-yl)]-(2,2,3,3-tetramethylcyclopropyl)methanone	219
(5-chloropentyl-UR-144);	220

(43)	221
[1-(5-bromopentylindol-3-yl)]-(2,2,3,3-tetramethylcyclopropyl)methanone	222
(5-bromopentyl-UR-144);	223

(44)	224
{1-[2-(4-morpholinyl)ethyl]indol-3-yl}-(2,2,3,3-tetramethylcyclopropyl)	225
methanone (A-796,260);	226

(45)	227
1-[(N-methylpiperidin-2-yl)methyl]-3-(1-adamantoyl)indole	228
(AM1248);	229

(46) N-adamantyl-1-(5-fluoropentylindole)-3-carboxamide;

230

(47) 5-(2-aminopropyl)benzofuran (5-APB);

231

(48) 6-(2-aminopropyl)benzofuran (6-APB);

232

(49) 5-(2-aminopropyl)-2,3-dihydrobenzofuran (5-APDB);

233

(50) 6-(2-aminopropyl)-2,3-dihydrobenzofuran (6-APDB);

234

(51) Benzothiophenylcyclohexylpiperidine (BTCP);

235

(52) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);

236

(53) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);

237

(54) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);

238

(55) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);

239

(56) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine	240
(2C-T-2);	241

(57) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine	242
(2C-T-4);	243

(58) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);

244

(59) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);

245

(60) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);

246

(61) 4-methoxymethamphetamine (PMMA);

247

(62) 5,6 - Methylenedioxy-2-aminoindane (MDAI);

248

(63) 5-iodo-2-aminoindiane (5-IAI);

249

(64) 2-(4-iodo-2,5-dimethoxyphenyl)-N-	250
[(2-methoxyphenyl)methyl]ethanamine(25I-NBOMe);	251

(65) Diphenylprolinol (diphenyl(pyrrolidin-2-yl)methanol,	252
D2PM);	253

(66) Desoxypipradrol (2-benzhydrylpiperidine);

254

(67) Synthetic cannabinoids - unless specifically excepted or	255
unless listed in another schedule, any material, compound,	256
mixture, or preparation that contains any quantity of a synthetic	257
cannabinoid found to be in any of the following chemical groups or	258
any of those groups which contain any synthetic cannabinoid salts,	259
isomers, or salts of isomers, whenever the existence of such	260
salts, isomers, or salts of isomers is possible within the	261
specific chemical groups:	262

(a) Naphthoylindoles: any compound containing a	263
3-(1-naphthoyl)indole structure with or without substitution at	264
the nitrogen atom of the indole ring by an alkyl, haloalkyl,	265
alkenyl, cycloalkylmethyl, cycloalkylethyl,	266
(N-methylpiperidin-2-yl)methyl, cyanoalkyl,	267
(N-methylpyrrolidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,	268
((N-methyl)-3-morpholinyl)methyl, or 2-(4-morpholinyl)ethyl group,	269
whether or not further substituted on the indole ring to any	270
extent or whether or not substituted on the naphthyl group to any	271
extent. Naphthoylindoles include, but are not limited to,	272
1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);	273
1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201),	274
1-pentyl-3-(1-naphthoyl)indole (JWH-018), and	275
1-butyl-3-(1-naphthoyl)indole (JWH-073).	276

(b) Naphthylmethylindoles: any compound containing a	277
1H-indol-3-yl-(1-naphthyl)methane structure with or without	278
substitution at the nitrogen atom of the indole ring by an alkyl,	279
haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,	280
(N-methylpiperidin-2-yl)methyl, cyanoalkyl,	281
(N-methylpyrrolidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,	282
((N-methyl)-3-morpholinyl)methyl, or 2-(4-morpholinyl)ethyl group,	283
whether or not further substituted on the indole ring to any	284
extent or whether or not substituted on the naphthyl group to any	285
extent. Naphthylmethylindoles include, but are not limited to,	286
(1-pentylindol-3-yl)(1-naphthyl)methane (JWH-175).	287

(c) Naphthoylpyrroles: any compound containing a	288
3-(1-naphthoyl)pyrrole structure with or without substitution at	289
the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl,	290
alkenyl, cycloalkylmethyl, cycloalkylethyl,	291
(N-methylpiperidin-2-yl)methyl, cyanoalkyl,	292
(N-methylpyrrolidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,	293
((N-methyl)-3-morpholinyl)methyl, or 2-(4-morpholinyl)ethyl group,	294
whether or not further substituted on the pyrrole ring to any	295
extent or whether or not substituted on the naphthyl group to any	296
extent. Naphthoylpyrroles include, but are not limited to,	297
1-hexyl-2-phenyl-4-(1-naphthoyl)pyrrole (JWH-147).	298

(d) Naphthylmethylindenes: any compound containing a	299
naphthylmethylideneindene structure with or without substitution	300
at the 3-position of the indene ring by an alkyl, haloalkyl,	301
alkenyl, cycloalkylmethyl, cycloalkylethyl,	302
(N-methylpiperidin-2-yl)methyl, cyanoalkyl,	303
(N-methylpyrrolidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,	304
((N-methyl)-3-morpholinyl)methyl, or 2-(4-morpholinyl)ethyl group,	305
whether or not further substituted on the indene group to any	306
extent or whether or not substituted on the naphthyl group to any	307
extent. Naphthylmethylindenes include, but are not limited to,	308
(1-[(3-pentyl)-1H-inden-1-ylidene)methyl]naphthalene (JWH-176).	309

(e) Phenylacetylindoles: any compound containing a	310
3-phenylacetylindole structure with or without substitution at the	311
nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,	312
cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl,	313
cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,	314
(tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl, or	315
2-(4-morpholinyl)ethyl group, whether or not further substituted	316
on the indole ring to any extent or whether or not substituted on	317
the phenyl group to any extent. Phenylacetylindoles include, but	318
are not limited to, 1-pentyl-3-(2-methoxyphenylacetyl)indole	319
(JWH-250), and	320
1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole (RCS-8);	321
1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).	322

(f) Cyclohexylphenols: any compound containing a	323
2-(3-hydroxycyclohexyl)phenol structure with or without	324
substitution at the 5-position of the phenolic ring by an alkyl,	325
haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,	326
(N-methylpiperidin-2-yl)methyl, cyanoalkyl,	327
(N-methylpyrrolidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,	328
((N-methyl)-3-morpholinyl)methyl, or 2-(4-morpholinyl)ethyl group,	329
whether or not further substituted on the cyclohexyl group to any	330
extent. Cyclohexylphenols include, but are not limited to,	331
5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol	332
(some trade or other names: CP-47,497) and	333
5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (some	334
trade or other names: cannabicyclohexanol; CP-47,497 C8	335
homologue).	336

(g) Benzoylindoles: any compound containing a	337
3-(1-naphthoyl)indole structure with or without substitution at	338
the nitrogen atom of the indole ring by an alkyl, haloalkyl,	339
alkenyl, cycloalkylmethyl, cycloalkylethyl,	340
(N-methylpiperidin-2-yl)methyl, cyanoalkyl,	341
(N-methylpyrrolidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl,	342
((N-methyl)-3-morpholinyl)methyl or 2-(4-morpholinyl)ethyl group,	343
whether or not further substituted on the indole ring to any	344
extent or whether or not substituted on the phenyl group to any	345
extent. Benzoylindoles include, but are not limited to,	346
1-pentyl-3-(4-methoxybenzoyl)indole (RCS-4),	347
1-[2-(4-morpholinyl)ethyl]-2-methyl-3-(4-methoxybenzoyl)indole	348
(Pravadoline or WIN 48, 098).	349

(D) Depressants

350

Any material, compound, mixture, or preparation that contains	351
any quantity of the following substances having a depressant	352
effect on the central nervous system, including their salts,	353
isomers, and salts of isomers, unless specifically excepted under	354
federal drug abuse control laws, whenever the existence of these	355
salts, isomers, and salts of isomers is possible within the	356
specific chemical designation:	357

(1) Mecloqualone;

358

(2) Methaqualone.

359

(E) Stimulants

360

Unless specifically excepted or unless listed in another	361
schedule, any material, compound, mixture, or preparation that	362
contains any quantity of the following substances having a	363
stimulant effect on the central nervous system, including their	364
salts, isomers, and salts of isomers:	365

(1) Aminorex (some other names: aminoxaphen;	366
2-amino-5-phenyl-2-oxazoline; or	367
4,5-dihydro-5-phenyl-2-oxazolamine);	368

(2) Fenethylline;

369

(3) (+/-)cis-4-methylaminorex	370
((+/-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);	371

(4) N-ethylamphetamine;

372

(5) N,N-dimethylamphetamine (also known as	373
N,N-alpha-trimethyl-benzeneethanamine;	374
N,N-alpha-trimethylphenethylamine);	375

(6) N-methyl-1-(thiophen-2-yl) propan-2-amine	376
(Methiopropamine);	377

(7) Substituted cathinones - any compound except bupropion or	378
compounds listed under a different schedule, structurally derived	379
from 2-aminopropan-1-one by substitution at the 1-position with	380
either phenyl, naphthyl, or thiophene ring systems, whether or not	381
the compound is further modified in any of the following ways:	382

(a) By substitution in the ring system to any extent with	383
alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide	384
substituents, whether or not further substituted in the ring	385
system by one or more other univalent substituents;	386

(b) By substitution at the 3-position with an acyclic alkyl	387
substituent;	388

(c) By substitution at the 2-amino nitrogen atom with alkyl,	389
dialkyl, benzyl, or methoxybenzyl groups;	390

(d) By inclusion of the 2-amino nitrogen atom in a cyclic	391
structure.	392

Examples of substituted cathinones include, but are not	393
limited to, methylone (3,4-methylenedioxymethcathinone), MDPV	394
(3,4-methylenedioxypyrovalerone), mephedrone	395
(4-methylmethcathinone), 4-methoxymethcathinone,	396
4-fluoromethcathinone, 3-fluoromethcathinone, Pentedrone	397
(2-(methylamino)-1-phenyl-1-pentanone), pentylone	398
(1-(1,3-benzodioxol-5-yl)-2-(methylamino)-1-pentanone),	399
2-(1-pyrrolidinyl)-1-(4-methylphenyl)-1-propanone, alpha-PVP	400
(1-phenyl-2-(1-pyrrodinyl)-1-pentanone), cathinone	401
(2-amino-1-phenyl-1-propanone), and methcathinone	402
(2-(methylamino)-propiophenone).	403

SCHEDULE II	404

(A) Narcotics-opium and opium derivatives

405

Unless specifically excepted under federal drug abuse control	406
laws or unless listed in another schedule, any of the following	407
substances whether produced directly or indirectly by extraction	408
from substances of vegetable origin, independently by means of	409
chemical synthesis, or by a combination of extraction and chemical	410
synthesis:	411

(1) Opium and opiate, and any salt, compound, derivative, or	412
preparation of opium or opiate, excluding apomorphine,	413
thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene,	414
naloxone, and naltrexone, and their respective salts, but	415
including the following:	416

(a) Raw opium;

417

(b) Opium extracts;

418

419

(d) Powdered opium;

420

(e) Granulated opium;

421

(f) Tincture of opium;

422

(g) Codeine;

423

(h) Ethylmorphine;

424

(i) Etorphine hydrochloride;

425

(j) Hydrocodone;

426

(k) Hydromorphone;

427

(l) Metopon;

428

(m) Morphine;

429

(n) Oxycodone;

430

(o) Oxymorphone;

431

(p) Thebaine.

432

(2) Any salt, compound, derivative, or preparation thereof	433
that is chemically equivalent to or identical with any of the	434
substances referred to in division (A)(1) of this schedule, except	435
that these substances shall not include the isoquinoline alkaloids	436
of opium;	437

(3) Opium poppy and poppy straw;

438

(4) Coca leaves and any salt, compound, derivative, or	439
preparation of coca leaves (including cocaine and ecgonine, their	440
salts, isomers, and derivatives, and salts of those isomers and	441
derivatives), and any salt, compound, derivative, or preparation	442
thereof that is chemically equivalent to or identical with any of	443
these substances, except that the substances shall not include	444
decocainized coca leaves or extraction of coca leaves, which	445
extractions do not contain cocaine or ecgonine;	446

(5) Concentrate of poppy straw (the crude extract of poppy	447
straw in either liquid, solid, or powder form that contains the	448
phenanthrene alkaloids of the opium poppy).	449

(B) Narcotics-opiates

450

Unless specifically excepted under federal drug abuse control	451
laws or unless listed in another schedule, any of the following	452
opiates, including their isomers, esters, ethers, salts, and salts	453
of isomers, esters, and ethers, whenever the existence of these	454
isomers, esters, ethers, and salts is possible within the specific	455
chemical designation, but excluding dextrorphan and	456
levopropoxyphene:	457

(1) Alfentanil;

458

(2) Alphaprodine;

459

(3) Anileridine;

460

(4) Bezitramide;

461

(5) Bulk dextropropoxyphene (non-dosage forms);

462

(6) Carfentanil;

463

(7) Dihydrocodeine;

464

(8) Diphenoxylate;

465

(9) Fentanyl;

466

(10) Isomethadone;

467

(11) Levo-alphacetylmethadol (some other names:	468
levo-alpha-acetylmethadol; levomethadyl acetate; LAAM);	469

(12) Levomethorphan;

470

(13) Levorphanol;

471

(14) Metazocine;

472

(15) Methadone;

473

(16) Methadone-intermediate,	474
4-cyano-2-dimethylamino-4,4-diphenyl butane;	475

(17) Moramide-intermediate,	476
2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid;	477

(18) Pethidine (meperidine);

478

(19) Pethidine-intermediate-A,	479
4-cyano-1-methyl-4-phenylpiperidine;	480

(20) Pethidine-intermediate-B,	481
ethyl-4-phenylpiperidine-4-carboxylate;	482

(21) Pethidine-intermediate-C,	483
1-methyl-4-phenylpiperidine-4-carboxylic acid;	484

(22) Phenazocine;

485

(23) Piminodine;

486

(24) Racemethorphan;

487

(25) Racemorphan;

488

(26) Remifentanil;

489

(27) Sufentanil.

490

491

Unless specifically excepted under federal drug abuse control	492
laws or unless listed in another schedule, any material, compound,	493
mixture, or preparation that contains any quantity of the	494
following substances having a stimulant effect on the central	495
nervous system:	496

(1) Amphetamine, its salts, its optical isomers, and salts of	497
its optical isomers;	498

(2) Methamphetamine, its salts, its isomers, and salts of its	499
isomers;	500

(3) Methylphenidate;

501

(4) Phenmetrazine and its salts.

502

(D) Depressants

503

Unless specifically excepted under federal drug abuse control	504
laws or unless listed in another schedule, any material, compound,	505
mixture, or preparation that contains any quantity of the	506
following substances having a depressant effect on the central	507
nervous system, including their salts, isomers, and salts of	508
isomers, whenever the existence of these salts, isomers, and salts	509
of isomers is possible within the specific chemical designation:	510

(1) Amobarbital;

511

(2) Gamma-hydroxy-butyrate;

512

(3) Glutethimide;

513

(4) Pentobarbital;

514

(5) Phencyclidine (some trade or other names:	515
1-(1-phenylcyclohexyl)piperidine; PCP);	516

(6) Secobarbital;

517

(7) 1-aminophenylcyclohexane and all N-mono-substituted	518
and/or all N-N-disubstituted analogs including, but not limited	519
to, the following:	520

(a) 1-phenylcyclohexylamine;

521

(b) (1-phenylcyclohexyl) methylamine;

522

523

(d) (1-phenylcyclohexyl) methylethylamine;

524

(e) (1-phenylcyclohexyl) isopropylamine;

525

(f) 1-(1-phenylcyclohexyl) morpholine.

526

(E) Hallucinogenic substances

527

(1) Nabilone (another name for nabilone:	528
(+)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-	529
hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one).	530

(F) Immediate precursors

531

Unless specifically excepted under federal drug abuse control	532
laws or unless listed in another schedule, any material, compound,	533
mixture, or preparation that contains any quantity of the	534
following substances:	535

(1) Immediate precursor to amphetamine and methamphetamine:

536

(a) Phenylacetone (some trade or other names:	537
phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl	538
ketone);	539

(2) Immediate precursors to phencyclidine (PCP):

540

(a) 1-phenylcyclohexylamine;

541

(b) 1-piperidinocyclohexanecarbonitrile (PCC).

542

SCHEDULE III	543

(A) Stimulants

544

Unless specifically excepted under federal drug abuse control	545
laws or unless listed in another schedule, any material, compound,	546
mixture, or preparation that contains any quantity of the	547
following substances having a stimulant effect on the central	548
nervous system, including their salts, their optical isomers,	549
position isomers, or geometric isomers, and salts of these	550
isomers, whenever the existence of these salts, isomers, and salts	551
of isomers is possible within the specific chemical designation:	552

(1) All stimulant compounds, mixtures, and preparations	553
included in schedule III pursuant to the federal drug abuse	554
control laws and regulations adopted under those laws;	555

(2) Benzphetamine;

556

(3) Chlorphentermine;

557

(4) Clortermine;

558

(5) Phendimetrazine.

559

(B) Depressants

560

Unless specifically excepted under federal drug abuse control	561
laws or unless listed in another schedule, any material, compound,	562
mixture, or preparation that contains any quantity of the	563
following substances having a depressant effect on the central	564
nervous system:	565

(1) Any compound, mixture, or preparation containing	566
amobarbital, secobarbital, pentobarbital, or any salt of any of	567
these drugs, and one or more other active medicinal ingredients	568
that are not listed in any schedule;	569

(2) Any suppository dosage form containing amobarbital,	570
secobarbital, pentobarbital, or any salt of any of these drugs and	571
approved by the food and drug administration for marketing only as	572
a suppository;	573

(3) Any substance that contains any quantity of a derivative	574
of barbituric acid or any salt of a derivative of barbituric acid;	575

(4) Chlorhexadol;

576

(5) Ketamine, its salts, isomers, and salts of isomers (some	577
other names for ketamine:	578
(+/-)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone);	579

(6) Lysergic acid;

580

(7) Lysergic acid amide;

581

(8) Methyprylon;

582

(9) Sulfondiethylmethane;

583

(10) Sulfonethylmethane;

584

(11) Sulfonmethane;

585

(12) Tiletamine, zolazepam, or any salt of tiletamine or	586
zolazepam (some trade or other names for a tiletamine-zolazepam	587
combination product: Telazol); (some trade or other names for	588
tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone); (some	589
trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-	590
dihydro-1,3,8-trimethylpyrazolo-[3, 4-e][1,4]-diazepin-7(1H)-one;	591
flupyrazapon).	592

593

(1) Nalorphine.

594

(D) Narcotics-narcotic preparations

595

Unless specifically excepted under federal drug abuse control	596
laws or unless listed in another schedule, any material, compound,	597
mixture, or preparation that contains any of the following	598
narcotic drugs, or their salts calculated as the free anhydrous	599
base or alkaloid, in limited quantities as set forth below:	600

(1) Not more than 1.8 grams of codeine per 100 milliliters or	601
not more than 90 milligrams per dosage unit, with an equal or	602
greater quantity of an isoquinoline alkaloid of opium;	603

(2) Not more than 1.8 grams of codeine per 100 milliliters or	604
not more than 90 milligrams per dosage unit, with one or more	605
active, nonnarcotic ingredients in recognized therapeutic amounts;	606

(3) Not more than 300 milligrams of dihydrocodeinone per 100	607
milliliters or not more than 15 milligrams per dosage unit, with a	608
fourfold or greater quantity of an isoquinoline alkaloid of opium;	609

(4) Not more than 300 milligrams of dihydrocodeinone per 100	610
milliliters or not more than 15 milligrams per dosage unit, with	611
one or more active, nonnarcotic ingredients in recognized	612
therapeutic amounts;	613

(5) Not more than 1.8 grams of dihydrocodeine per 100	614
milliliters or not more than 90 milligrams per dosage unit, with	615
one or more active, nonnarcotic ingredients in recognized	616
therapeutic amounts;	617

(6) Not more than 300 milligrams of ethylmorphine per 100	618
milliliters or not more than 15 milligrams per dosage unit, with	619
one or more active, nonnarcotic ingredients in recognized	620
therapeutic amounts;	621

(7) Not more than 500 milligrams of opium per 100 milliliters	622
or per 100 grams or not more than 25 milligrams per dosage unit,	623
with one or more active, nonnarcotic ingredients in recognized	624
therapeutic amounts;	625

(8) Not more than 50 milligrams of morphine per 100	626
milliliters or per 100 grams, with one or more active, nonnarcotic	627
ingredients in recognized therapeutic amounts.	628

(E) Anabolic steroids

629

Unless specifically excepted under federal drug abuse control	630
laws or unless listed in another schedule, any material, compound,	631
mixture, or preparation that contains any quantity of the	632
following substances, including their salts, esters, isomers, and	633
salts of esters and isomers, whenever the existence of these	634
salts, esters, and isomers is possible within the specific	635
chemical designation:	636

(1) Anabolic steroids. Except as otherwise provided in	637
division (E)(1) of schedule III, "anabolic steroids" means any	638
drug or hormonal substance that is chemically and	639
pharmacologically related to testosterone (other than estrogens,	640
progestins, and corticosteroids) and that promotes muscle growth.	641
"Anabolic steroids" does not include an anabolic steroid that is	642
expressly intended for administration through implants to cattle	643
or other nonhuman species and that has been approved by the United	644
States secretary of health and human services for that	645
administration, unless a person prescribes, dispenses, or	646
distributes this type of anabolic steroid for human use. "Anabolic	647
steroid" includes, but is not limited to, the following:	648

(a) Boldenone;

649

(b) Chlorotestosterone (4-chlortestosterone);

650

651

(d) Dehydrochlormethyltestosterone;

652

(e) Dihydrotestosterone (4-dihydrotestosterone);

653

(f) Drostanolone;

654

(g) Ethylestrenol;

655

(h) Fluoxymesterone;

656

(i) Formebulone (formebolone);

657

(j) Mesterolone;

658

(k) Methandienone;

659

(l) Methandranone;

660

(m) Methandriol;

661

(n) Methandrostenolone;

662

(o) Methenolone;

663

(p) Methyltestosterone;

664

(q) Mibolerone;

665

(r) Nandrolone;

666

(s) Norethandrolone;

667

(t) Oxandrolone;

668

(u) Oxymesterone;

669

(v) Oxymetholone;

670

(w) Stanolone;

671

(x) Stanozolol;

672

(y) Testolactone;

673

(z) Testosterone;

674

(aa) Trenbolone;

675

(bb) Any salt, ester, isomer, or salt of an ester or isomer	676
of a drug or hormonal substance described or listed in division	677
(E)(1) of schedule III if the salt, ester, or isomer promotes	678
muscle growth.	679

(F) Hallucinogenic substances

680

(1) Dronabinol (synthetic) in sesame oil and encapsulated in	681
a soft gelatin capsule in a United States food and drug	682
administration approved drug product (some other names for	683
dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-	684
6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or	685
(-)-delta-9-(trans)-tetrahydrocannabinol).	686

SCHEDULE IV	687

(A) Narcotic drugs

688

Unless specifically excepted by federal drug abuse control	689
laws or unless listed in another schedule, any material, compound,	690
mixture, or preparation that contains any of the following	691
narcotic drugs, or their salts calculated as the free anhydrous	692
base or alkaloid, in limited quantities as set forth below:	693

(1) Not more than one milligram of difenoxin and not less	694
than 25 micrograms of atropine sulfate per dosage unit;	695

(2) Dextropropoxyphene	696
(alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-	697
propionoxybutane)[final dosage forms].	698

(B) Depressants

699

Unless specifically excepted under federal drug abuse control	700
laws or unless listed in another schedule, any material, compound,	701
mixture, or preparation that contains any quantity of the	702
following substances, including their salts, isomers, and salts of	703
isomers, whenever the existence of these salts, isomers, and salts	704
of isomers is possible within the specific chemical designation:	705

(1) Alprazolam;

706

(2) Barbital;

707

(3) Bromazepam;

708

(4) Camazepam;

709

(5) Chloral betaine;

710

(6) Chloral hydrate;

711

(7) Chlordiazepoxide;

712

(8) Clobazam;

713

(9) Clonazepam;

714

(10) Clorazepate;

715

(11) Clotiazepam;

716

(12) Cloxazolam;

717

(13) Delorazepam;

718

(14) Diazepam;

719

(15) Estazolam;

720

(16) Ethchlorvynol;

721

(17) Ethinamate;

722

(18) Ethyl loflazepate;

723

(19) Fludiazepam;

724

(20) Flunitrazepam;

725

(21) Flurazepam;

726

(22) Halazepam;

727

(23) Haloxazolam;

728

(24) Ketazolam;

729

(25) Loprazolam;

730

(26) Lorazepam;

731

(27) Lormetazepam;

732

(28) Mebutamate;

733

(29) Medazepam;

734

(30) Meprobamate;

735

(31) Methohexital;

736

(32) Methylphenobarbital (mephobarbital);

737

(33) Midazolam;

738

(34) Nimetazepam;

739

(35) Nitrazepam;

740

(36) Nordiazepam;

741

(37) Oxazepam;

742

(38) Oxazolam;

743

(39) Paraldehyde;

744

(40) Petrichloral;

745

(41) Phenobarbital;

746

(42) Pinazepam;

747

(43) Prazepam;

748

(44) Quazepam;

749

(45) Temazepam;

750

(46) Tetrazepam;

751

(47) Triazolam;

752

(48) Zaleplon;

753

(49) Zolpidem.

754

755

Any material, compound, mixture, or preparation that contains	756
any quantity of the following substances, including their salts,	757
their optical isomers, position isomers, or geometric isomers, and	758
salts of these isomers, whenever the existence of these salts,	759
isomers, and salts of isomers is possible within the specific	760
chemical designation:	761

(1) Fenfluramine.

762

(D) Stimulants

763

Unless specifically excepted under federal drug abuse control	764
laws or unless listed in another schedule, any material, compound,	765
mixture, or preparation that contains any quantity of the	766
following substances having a stimulant effect on the central	767
nervous system, including their salts, their optical isomers,	768
position isomers, or geometric isomers, and salts of these	769
isomers, whenever the existence of these salts, isomers, and salts	770
of isomers is possible within the specific chemical designation:	771

(1) Cathine ((+)-norpseudoephedrine);

772

(2) Diethylpropion;

773

(3) Fencamfamin;

774

(4) Fenproporex;

775

(5) Mazindol;

776

(6) Mefenorex;

777

(7) Modafinil;

778

(8) Pemoline (including organometallic complexes and chelates	779
thereof);	780

(9) Phentermine;

781

(10) Pipradrol;

782

(11) Sibutramine;

783

(12) SPA [(-)-1-dimethylamino-1,2-diphenylethane].

784

(E) Other substances

785

Unless specifically excepted under federal drug abuse control	786
laws or unless listed in another schedule, any material, compound,	787
mixture, or preparation that contains any quantity of the	788
following substances, including their salts:	789

(1) Pentazocine;

790

(2) Butorphanol (including its optical isomers).

791

SCHEDULE V	792

(A) Narcotic drugs

793

Unless specifically excepted under federal drug abuse control	794
laws or unless listed in another schedule, any material, compound,	795
mixture, or preparation that contains any of the following	796
narcotic drugs, and their salts, as set forth below:	797

(1) Buprenorphine.

798

(B) Narcotics-narcotic preparations

799

Narcotic drugs containing non-narcotic active medicinal	800
ingredients. Any compound, mixture, or preparation that contains	801
any of the following narcotic drugs, or their salts calculated as	802
the free anhydrous base or alkaloid, in limited quantities as set	803
forth below, and that includes one or more nonnarcotic active	804
medicinal ingredients in sufficient proportion to confer upon the	805
compound, mixture, or preparation valuable medicinal qualities	806
other than those possessed by narcotic drugs alone:	807

(1) Not more than 200 milligrams of codeine per 100	808
milliliters or per 100 grams;	809

(2) Not more than 100 milligrams of dihydrocodeine per 100	810
milliliters or per 100 grams;	811

(3) Not more than 100 milligrams of ethylmorphine per 100	812
milliliters or per 100 grams;	813

(4) Not more than 2.5 milligrams of diphenoxylate and not	814
less than 25 micrograms of atropine sulfate per dosage unit;	815

(5) Not more than 100 milligrams of opium per 100 milliliters	816
or per 100 grams;	817

(6) Not more than 0.5 milligram of difenoxin and not less	818
than 25 micrograms of atropine sulfate per dosage unit.	819

820

Unless specifically exempted or excluded under federal drug	821
abuse control laws or unless listed in another schedule, any	822
material, compound, mixture, or preparation that contains any	823
quantity of the following substances having a stimulant effect on	824
the central nervous system, including their salts, isomers, and	825
salts of isomers:	826